iPSC-Derived Human Cardiomyocytes Kit (African-American, Male Line)
Catalog # :
Applied StemCell has developed an efficient integration-free, small molecule-based method to differentiate high-quality cardiomyocytes from human iPSCs. The differentiated cardiomyocytes recapitulate the phenotype and functional parameters of primary and in vivo cardiomyocytes.
We provide cardiomyocytes differentiated from an integration-free, control human iPSC line (ASE-9211), reprogrammed from the fibroblasts of an African-American male donor. These high-purity cells beat in 2-3 days after recovery and express high level of cTnT. These cryopreserved cardiomyocytes are ready-to-use in 2-3 days after recovery and are functionally viable for 7-14 days after recovery.